TrialCancer research and treatment2019

S-1 Based Doublet as an Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer: Results from the Randomized Phase III POST Trial.

Choong-Kun Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.